Opdualag 240-80 MG/20 ML vial 20ML
Ended Awarded
- Contract number
- SPE2DB25FP9A1
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $49,184
Award facts
- Contract value 100% obligated
- $49,183.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $49,183.60 delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Opdualag 240-80 mg/20 ml vials. This firm fixed-price contract represents a non-competitive set-aside delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to AmerisourceBergen's corporate headquarters location in Conshohocken, Pennsylvania, with an ultimate completion date of September 8, 2025. As a major pharmaceutical distributor and critical federal healthcare vendor, AmerisourceBergen maintains a comprehensive portfolio of medical supply contracts serving military and veteran healthcare systems.
This delivery order operates under AmerisourceBergen's prime $999.999 billion IDC with DLA Troop Support Medical (Contract SPE2DX), which extends through December 2026 and functions as a global pharmaceutical support vehicle. The parent contract enables the company to supply an extensive range of pharmaceutical products, medical devices, vaccines, and specialized healthcare commodities across multiple therapeutic domains to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard. The underlying IDC framework demonstrates AmerisourceBergen's established capability to meet federal medical procurement requirements and reflects DLA's strategic approach to maintaining multiple qualified pharmaceutical prime vendors for regional coverage.
Quick answers
Who was awarded contract SPE2DB25FP9A1?
SPE2DB25FP9A1 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 15, 2025.
How much is contract SPE2DB25FP9A1 worth?
The government has obligated $49,184 on SPE2DB25FP9A1.
Is contract SPE2DB25FP9A1 an order under another contract?
Yes. SPE2DB25FP9A1 is a delivery order under SPE2DB20D3103, an indefinite delivery contract.
Was contract SPE2DB25FP9A1 competed?
The extent of competition for SPE2DB25FP9A1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award